These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4948222)

  • 21. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newer hypolipidemic agents.
    Kritchevsky D
    Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
    [No Abstract]   [Full Text] [Related]  

  • 23. Phosphonomycin. I. Discovery and in vitro biological characterization.
    Stapley EO; Hendlin D; Mata JM; Jackson M; Wallick H; Hernandez S; Mochales S; Currie SA; Miller RM
    Antimicrob Agents Chemother (Bethesda); 1969; 9():284-90. PubMed ID: 5396502
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of ansamycin against Mycobacterium leprae in mice.
    Hastings RC; Jacobson RR
    Lancet; 1983 Nov; 2(8358):1079-80. PubMed ID: 6138619
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
    Dutta GN; Devriese LA
    Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacology and in vitro activity of phosphonomycin.
    Kestle DG; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1969; 9():332-7. PubMed ID: 5396510
    [No Abstract]   [Full Text] [Related]  

  • 28. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two new types of resistance to lincomycin in pathogenic staphylococci from animals.
    Devriese LA
    Ann Microbiol (Paris); 1980; 131B(3):261-6. PubMed ID: 7469255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ansamycin activity against rifampicin-resistant Mycobacterium leprae.
    Hastings RC; Richard VR; Jacobson RR
    Lancet; 1984 May; 1(8386):1130. PubMed ID: 6144865
    [No Abstract]   [Full Text] [Related]  

  • 31. [The sensitivity of pathogenic staphylococci of human origin to two recent antibiotics: cephalotin and lincomycin].
    Fleurette J
    Ann Biol Clin (Paris); 1968; 26(5):673-80. PubMed ID: 5681856
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo activities of novel benzoxazinorifamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    Indian J Lepr; 1995; 67(4):375-82. PubMed ID: 8849914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.
    Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Watanabe T; Yamamoto M; Hirai Y; Ajito K
    J Antibiot (Tokyo); 2016 Jun; 69(6):428-39. PubMed ID: 26669751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lincosamides: chemical structure, biosynthesis, mechanism of action, resistance, and applications.
    Spízek J; Novotná J; Rezanka T
    Adv Appl Microbiol; 2004; 56():121-54. PubMed ID: 15566978
    [No Abstract]   [Full Text] [Related]  

  • 35. The mouse footpad test--sensitive to small proportions of drug-resistant bacilli in a sample of M. leprae.
    Almeida JG; Joseph PS; Sarangapani G; Chacko CJ
    Indian J Lepr; 1984; 56(1):10-4. PubMed ID: 6384379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphonomycin. IV. Susceptibility testing method and survey.
    Zimmerman SB; Stapley EO; Wallick H; Baldwin R
    Antimicrob Agents Chemother (Bethesda); 1969; 9():303-9. PubMed ID: 5396505
    [No Abstract]   [Full Text] [Related]  

  • 38. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin.
    McGehee RF R; Barre FF; Finland M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():392-7. PubMed ID: 5735385
    [No Abstract]   [Full Text] [Related]  

  • 39. Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro.
    Franzblau SG; White KE; O'Sullivan JF
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2004-5. PubMed ID: 2692516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sensitivity of Streptococcus and Staphylococcus of various serological and bacteriophage groups to lincomycin; resistance of Gram-negative bacteria in urinary infections].
    von Hubinger MG; Suassuna I; Suassuna IR; Oliveira Lde A
    Hospital (Rio J); 1966 Apr; 69(4):691-9. PubMed ID: 5295887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.